Menopause, Premature clinical trials
The registry lists 24 studies for Menopause, Premature across more than 10 countries. 5 are recruiting or about to start. 8 of them are mainly about Menopause, Premature (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-08.
Get an email when these change. Save the Menopause, Premature studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3) · Radboud University Medical Center (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · University of Illinois at Chicago (1) · Ryazan State Medical University (1) · Navy General Hospital, Beijing (1) · Insel Gruppe AG, University Hospital Bern (1) · National Taiwan University Hospital (1)
What is being tested here
Drugs under test in Menopause, Premature studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3, phase 3 first
- Jan 2027Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients · Phase 3 · Genesis Athens Clinic
- Dec 2026Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women · University of Minnesota
- May 2027Improving Outcomes in Early Menopause After Cancer · Duke University
Who these studies take
Of the 4 Menopause, Premature studies recruiting now, 0 (0%) set no upper age limit and 4 (100%) stop at 75 or younger. 0 (0%) take children under 18. 4 (100%) are for women only and 0 (0%) for men only; 3 (75%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (25%) | 0 (0%) |
| 30 | 3 (75%) | 0 (0%) |
| 40 | 3 (75%) | 0 (0%) |
| 50 | 1 (25%) | 0 (0%) |
| 65 | 1 (25%) | 0 (0%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 24 studies, recruiting or not: 79% stop at 75 or younger and 71% at 65; 13% take children; 100% are for women only and 0% for men only; 50% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 24 of 24. search them.
- Effects of Estrogen on Heart Health in Women With Primary Ovarian InsufficiencyRecruitingNCT068661191 country
- Ovarian Tissue Allo-transplantationNot yet recruitingNCT06673004Not applicable1 country
- Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI PatientsRecruitingNCT04031456Phase 2/31 country
- Improving Outcomes in Early Menopause After CancerRecruitingNCT06982677Not applicable1 country
- Autonomic Regulation of Blood Pressure in Premature and Early Menopausal WomenRecruitingNCT044393701 country
- Nurse-led Mind-body Intervention on Sexual Health for Breast Cancer SurvivorsCompletedNCT06307470Not applicable1 country
- A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY TrialActive, not recruitingNCT06497270Not applicable1 country
- Injections of Autologous PRP in Women With Primary Ovarian InsufficiencyCompletedNCT03542708Not applicable1 country
- Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian FailureCompletedNCT04943354Not applicable1 country
- Turner Syndrome Minipuberty StudyStatus unknownNCT041894065 countries
- Rejuvenation of Premature Ovarian Failure With Stem CellsCompletedNCT02696889Not applicable1 country
- Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the OvaryTerminatedNCT02780791Not applicable1 country
- Stem Cell Therapy and Growth Factor Ovarian in Vitro ActivationStatus unknownNCT04009473Phase 1/23 countries
- Inovium Ovarian Rejuvenation TrialsCompletedNCT03178695Phase 11 country
- Causes and Consequences of Primary Ovarian InsufficiencyStatus unknownNCT040821691 country
- Endocan Levels in Women With Premature Ovarian InsufficiencyCompletedNCT039246481 country
- The Natural History of Reproductive and Overall Health in Girls and Women With a Pre-Mutation in the FMR1 Gene; Creation of a Patient RegistryTerminatedNCT011875241 country
- Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian FailureWithdrawnNCT00370019Phase 21 country
- The Longitudinal Ovarian Reserve StudyCompletedNCT023953411 country
- Oral Contraceptives as Infertility Treatments for Premature Ovarian FailureStatus unknownNCT02757469Not applicable1 country
- The Role of Vitamin D in Menopause: Relationship to Menopausal Symptoms in Body CompositionCompletedNCT01141972Phase 11 country
- Feasibility Study for Development of an Early Test for Ovarian FailureCompletedNCT00006156Not applicable1 country
- Impact of Treatment Induced Premature Menopause on Quality of LifeCompletedNCT001857181 country
- Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal WomenStatus unknownNCT001735501 country